Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis

Research output: Contribution to journal › Journal article › Research › peer-review

  • Bodil Petersen
  • Klaus Bendtzen
  • Nils Koch-Henriksen
  • Mads Ravnborg
  • Pedersen, Christian Ross
  • Per Soelberg Sorensen
  • Danish Multiple Sclerosis Group
The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.
Original languageEnglish
JournalMultiple Sclerosis
Volume12
Issue number3
Pages (from-to)247-52
Number of pages6
ISSN1352-4585
Publication statusPublished - 1 Jun 2006

ID: 34085400